Athanor Capital, LP Puma Biotechnology, Inc. Transaction History

Athanor Capital, LP

  • $24.6 Million
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$8.98 - $11.6 $163,112 - $210,702
-18,164 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$9.38 - $13.63 $44,958 - $65,328
4,793 Added 35.85%
18,164 $177,000
Q3 2020

Nov 16, 2020
SELL
$9.5 - $11.14 $101,431 - $118,941
-10,677 Reduced 44.4%
13,371 $135,000
Q2 2020

Aug 13, 2020
BUY
$7.01 - $13.24 $168,576 - $318,395
24,048 New
24,048 $251,000

Others Institutions Holding PBYI

# of Institutions
101
Shares Held
29M
Call Options Held
50.6K
Put Options Held
16.3K
View Full List

About PUMA BIOTECHNOLOGY, INC.

PBYI Quotes by TradingView
  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $137M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Athanor Capital, LP Portfolio

Follow Athanor Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Athanor Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email